SPASFON, solution injectable en ampoule — 6 ampoule(s) en verre de 4 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930985830 -
CIP7
3098583 -
CIS
62998997
What the source publishes
- Holder
- TEVA SANTE
- Active ingredients
- PHLOROGLUCINOL HYDRATÉ, TRIMÉTHYLPHLOROGLUCINOL, PHLOROGLUCINOL ANHYDRE
- Form
- solution injectable
- Package
- 6 ampoule(s) en verre de 4 ml
- Routes
- intramusculaire, intraveineuse
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 1993-12-01
- Prescription
- Prescription or restricted
Names this record is found by
- SPASFON, solution injectable en ampoule — 6 ampoule(s) en verre de 4 ml
- SPASFON, solution injectable en ampoule
- PHLOROGLUCINOL HYDRATÉ
- TRIMÉTHYLPHLOROGLUCINOL
- PHLOROGLUCINOL ANHYDRE
Complete source data
{
"cis": "62998997",
"cip7": "3098583",
"form": "solution injectable",
"name": "SPASFON, solution injectable en ampoule — 6 ampoule(s) en verre de 4 ml",
"cip13": "3400930985830",
"holder": "TEVA SANTE",
"routes": [
"intramusculaire",
"intraveineuse"
],
"holders": [
"TEVA SANTE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "3.76",
"authorisedOn": "1993-12-01",
"compositions": [
{
"name": "PHLOROGLUCINOL HYDRATÉ",
"nature": "SA",
"strength": "40 mg",
"linkageNumber": "2",
"substanceCode": "03969",
"dosageReference": "une ampoule",
"pharmaceuticalElement": "solution"
},
{
"name": "TRIMÉTHYLPHLOROGLUCINOL",
"nature": "SA",
"strength": "0,040 mg",
"linkageNumber": "3",
"substanceCode": "03970",
"dosageReference": "une ampoule",
"pharmaceuticalElement": "solution"
},
{
"name": "PHLOROGLUCINOL ANHYDRE",
"nature": "FT",
"strength": "31,12 mg",
"linkageNumber": "2",
"substanceCode": "40521",
"dosageReference": "une ampoule",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "2.74",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "SPASFON, solution injectable en ampoule",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "6 ampoule(s) en verre de 4 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"15%"
],
"marketingDeclaredOn": "1965-04-19",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"PHLOROGLUCINOL HYDRATÉ",
"TRIMÉTHYLPHLOROGLUCINOL",
"PHLOROGLUCINOL ANHYDRE"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Douleurs liées à des troubles fonctionnels intestinaux<br>- Spasmes douloureux aiguës des voies urinaires : coliques néphrétiques<br>- Spasmes douloureux gynécologiques<br>- Spasmes douloureux au cours de la grossesse ; JOURNAL OFFICIEL ; 13/06/13",
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930985830"